Scinovex
articleTop 1% cited

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Science · 1993 · Vol. 261(5123) · pp. 921–923

Abstract

The apolipoprotein E type 4 allele (APOE-epsilon 4) is genetically associated with the common late onset familial and sporadic forms of Alzheimer's disease (AD). Risk for AD increased from 20% to 90% and mean age at onset decreased from 84 to 68 years with increasing number of APOE-epsilon 4 alleles in 42 families with late onset AD. Thus APOE-epsilon 4 gene dose is a major risk factor for late onset AD and, in these families, homozygosity for APOE-epsilon 4 was virtually sufficient to cause AD by age 80.

Alzheimer's disease research and treatmentsNuclear Receptors and SignalingCholinesterase and Neurodegenerative DiseasesApolipoprotein EAlleleAge of onsetRisk factorDiseaseAlzheimer's diseaseGeneticsDegenerative diseaseBiologyMedicine

MeSH terms

AgedAged, 80 and overAgingAllelesAlzheimer DiseaseApolipoproteins EFemaleGene FrequencyGenotypeHomozygoteHumansMaleRisk FactorsLinkage DisequilibriumSurvival Rate
Citations
9,373
FWCI
112.42
field-weighted impact
References
16
Percentile
100%
vs. same field & year
Citations per year
Cited by
Alzheimer's Disease: Genes, Proteins, and Therapy
Physiological Reviews · 2001 · 6,050 citations
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
Science Translational Medicine · 2011 · 1,172 citations
Neurodegenerative Tauopathies
Annual Review of Neuroscience · 2001 · 2,357 citations
Microglia in Alzheimer’s disease
The Journal of Cell Biology · 2017 · 1,898 citations
Brain Cholesterol: Long Secret Life Behind a Barrier
Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 1,007 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.